1. The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines. Issue 11 (March 2016) Authors: Guan, Xiuwen; Wang, Haijuan; Ma, Fei; Qian, Haili; Yi, Zongbi; Xu, Binghe Editors: La-Beck., Ninh (Irene) Journal: Medicine Issue: Volume 95:Issue 11(2016) Page Start: e3134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗